Cargando…

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study

BACKGROUND: Postprandial hyperglycemia is believed to affect vascular endothelial function. The aim of our study was to compare the effects of acarbose and nateglinide on postprandial endothelial dysfunction. METHODS: We recruited a total of 30 patients with newly diagnosed type 2 diabetes (19 men a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Toru, Inoue, Teruo, Node, Koichi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Original investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861640/ https://www.ncbi.nlm.nih.gov/pubmed/20334663 http://dx.doi.org/10.1186/1475-2840-9-12

Ejemplares similares

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
por: Noda, Yoko, et al.
Publicado: (2013)

Postprandial hyperglycemia as an etiological factor in vascular failure
por: Node, Koichi, et al.
Publicado: (2009)

Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia
por: Kitano, Daisuke, et al.
Publicado: (2013)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance
por: Suzuki, Kazunari, et al.
Publicado: (2012)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study
por: Ohno, Yuko, et al.
Publicado: (2014)

Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
por: Wang, Leilei, et al.
Publicado: (2013)

A Case of Postprandial Hypotension in the Intensive Care Unit Treated With Acarbose
por: Choi, Joon Hyouk, et al.
Publicado: (2011)

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naïve Japanese patients with type 2 diabetes mellitus: A pilot study
por: Tanimoto, Masumi, et al.
Publicado: (2015)

A review of nateglinide in the management of patients with type 2 diabetes
por: Tentolouris, Nicholas, et al.
Publicado: (2007)

Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study
por: Maruhashi, Tatsuya, et al.
Publicado: (2016)

A case of postprandial hypotension in an individual with cervical spinal cord injury: treatment with acarbose
por: Farrehi, Clara, et al.
Publicado: (2019)

Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis
por: Wang, Biqing, et al.
Publicado: (2021)

Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes
por: Kim, Ji-Hyun, et al.
Publicado: (2015)

GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy
por: Shiraki, Aya, et al.
Publicado: (2019)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
por: Israel, Marc K, et al.
Publicado: (2008)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

Cyanidin-3-rutinoside alleviates postprandial hyperglycemia and its synergism with acarbose by inhibition of intestinal α-glucosidase
por: Adisakwattana, Sirichai, et al.
Publicado: (2011)

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report
por: Nakamura, Ikuko, et al.
Publicado: (2014)

Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension
por: Ryakala, Harika, et al.
Publicado: (2015)

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma
por: Pani, Nihar Ranjan, et al.
Publicado: (2012)

Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals
por: NOGUCHI, KAORU, et al.
Publicado: (2015)

Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

Helical‐Like Assembly of Nateglinide as Coating for Oral Delivery of Insulin and Their Synergistic Prevention of Diabetes Mellitus
por: Li, Yanfei, et al.
Publicado: (2023)

Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment
por: Node, Koichi, et al.
Publicado: (2009)

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
por: Zheng, Miao-yan, et al.
Publicado: (2013)

Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes and dyslipidemia: a preliminary report
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
por: Hiyoshi, Toru, et al.
Publicado: (2019)

Acarbose is again on the stage
por: Altay, Mustafa
Publicado: (2022)

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study
por: Sagara, Masaaki, et al.
Publicado: (2016)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
por: Ansar, Sameer, et al.
Publicado: (2011)

Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001)

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
por: Uzui, Hiroyasu, et al.
Publicado: (2011)

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial
por: Tripolt, Norbert J., et al.
Publicado: (2018)

Renal Outcomes of Pioglitazone Compared with Acarbose in Diabetic Patients: A Randomized Controlled Study
por: Chen, Yu-Hsin, et al.
Publicado: (2016)

Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
por: He, Ke, et al.
Publicado: (2014)

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_52oh81653iv1m4q482fs7g2b4n